vs
Digimarc CORP（DMRC）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是Digimarc CORP的1.0倍（$9.2M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -234.3%，领先187.1%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 2.9%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
DMRC vs FHTX — 直观对比
营收规模更大
FHTX
是对方的1.0倍
$8.9M
营收增速更快
FHTX
高出220.9%
2.9%
净利率更高
DMRC
高出187.1%
-234.3%
两年增速更快
FHTX
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $9.2M |
| 净利润 | $-4.2M | $-21.7M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -258.2% |
| 净利率 | -47.2% | -234.3% |
| 营收同比 | 2.9% | 223.8% |
| 净利润同比 | 51.4% | -11.1% |
| 每股收益（稀释后） | $-0.18 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCFHTX
| Q4 25 | $8.9M | $9.2M | ||
| Q3 25 | $7.6M | $8.2M | ||
| Q2 25 | $8.0M | $7.6M | ||
| Q1 25 | $9.4M | $6.0M | ||
| Q4 24 | $8.7M | $2.9M | ||
| Q3 24 | $9.4M | $7.8M | ||
| Q2 24 | $10.4M | $6.9M | ||
| Q1 24 | $9.9M | $5.0M |
净利润DMRCFHTX
| Q4 25 | $-4.2M | $-21.7M | ||
| Q3 25 | $-8.2M | $-15.8M | ||
| Q2 25 | $-8.2M | $-17.9M | ||
| Q1 25 | $-11.7M | $-18.8M | ||
| Q4 24 | $-8.6M | $-19.5M | ||
| Q3 24 | $-10.8M | $-19.1M | ||
| Q2 24 | $-9.3M | $-23.0M | ||
| Q1 24 | $-10.3M | $-25.0M |
毛利率DMRCFHTX
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCFHTX
| Q4 25 | -48.2% | -258.2% | ||
| Q3 25 | -109.7% | -226.9% | ||
| Q2 25 | -105.2% | -279.2% | ||
| Q1 25 | -128.9% | -385.0% | ||
| Q4 24 | -105.1% | -840.5% | ||
| Q3 24 | -120.4% | -305.5% | ||
| Q2 24 | -96.2% | -386.6% | ||
| Q1 24 | -109.2% | -558.3% |
净利率DMRCFHTX
| Q4 25 | -47.2% | -234.3% | ||
| Q3 25 | -106.9% | -194.4% | ||
| Q2 25 | -102.6% | -237.3% | ||
| Q1 25 | -125.2% | -316.4% | ||
| Q4 24 | -99.9% | -682.9% | ||
| Q3 24 | -113.9% | -244.9% | ||
| Q2 24 | -89.3% | -333.6% | ||
| Q1 24 | -104.0% | -495.4% |
每股收益（稀释后）DMRCFHTX
| Q4 25 | $-0.18 | $-0.35 | ||
| Q3 25 | $-0.38 | $-0.25 | ||
| Q2 25 | $-0.38 | $-0.28 | ||
| Q1 25 | $-0.55 | $-0.30 | ||
| Q4 24 | $-0.40 | $-0.23 | ||
| Q3 24 | $-0.50 | $-0.31 | ||
| Q2 24 | $-0.43 | $-0.45 | ||
| Q1 24 | $-0.50 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $80.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $-108.5M |
| 总资产 | $53.0M | $198.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCFHTX
| Q4 25 | $12.9M | $80.9M | ||
| Q3 25 | $12.6M | $89.3M | ||
| Q2 25 | $16.1M | $72.6M | ||
| Q1 25 | $21.6M | $61.0M | ||
| Q4 24 | $28.7M | $55.5M | ||
| Q3 24 | $33.7M | $57.7M | ||
| Q2 24 | $41.5M | $138.9M | ||
| Q1 24 | $48.9M | $79.3M |
股东权益DMRCFHTX
| Q4 25 | $40.2M | $-108.5M | ||
| Q3 25 | $41.4M | $-89.7M | ||
| Q2 25 | $46.5M | $-76.7M | ||
| Q1 25 | $50.0M | $-61.7M | ||
| Q4 24 | $61.4M | $-45.5M | ||
| Q3 24 | $70.2M | $-28.3M | ||
| Q2 24 | $77.2M | $-14.3M | ||
| Q1 24 | $84.5M | $-97.5M |
总资产DMRCFHTX
| Q4 25 | $53.0M | $198.1M | ||
| Q3 25 | $55.4M | $205.0M | ||
| Q2 25 | $60.7M | $226.2M | ||
| Q1 25 | $66.5M | $258.7M | ||
| Q4 24 | $75.8M | $284.0M | ||
| Q3 24 | $85.0M | $308.4M | ||
| Q2 24 | $93.4M | $328.6M | ||
| Q1 24 | $99.7M | $255.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCFHTX
| Q4 25 | $991.0K | $-22.3M | ||
| Q3 25 | $-2.6M | $-18.9M | ||
| Q2 25 | $-4.7M | $-21.0M | ||
| Q1 25 | $-5.5M | $-24.0M | ||
| Q4 24 | $-4.2M | $-24.5M | ||
| Q3 24 | $-7.1M | $-21.0M | ||
| Q2 24 | $-6.8M | $-25.5M | ||
| Q1 24 | $-8.4M | $-29.3M |
自由现金流DMRCFHTX
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | $-21.0M | ||
| Q1 25 | $-5.5M | $-24.0M | ||
| Q4 24 | $-4.2M | $-25.0M | ||
| Q3 24 | $-7.2M | $-21.3M | ||
| Q2 24 | $-6.9M | $-25.6M | ||
| Q1 24 | $-8.5M | $-29.4M |
自由现金流率DMRCFHTX
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | -278.2% | ||
| Q1 25 | -59.1% | -403.2% | ||
| Q4 24 | -49.1% | -875.3% | ||
| Q3 24 | -75.7% | -273.0% | ||
| Q2 24 | -66.1% | -371.0% | ||
| Q1 24 | -85.8% | -583.1% |
资本支出强度DMRCFHTX
| Q4 25 | 1.1% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 2.5% | 0.3% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.2% | 16.8% | ||
| Q3 24 | 0.7% | 4.0% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 1.1% | 2.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
FHTX
暂无分部数据
